Stockscreener 앱 받기
5.77
7.97%
-0.50
시간 외 거래:
5.79
0.02
+0.35%
전일 마감가:
$6.27
열려 있는:
$6.08
하루 거래량:
211.86K
Relative Volume:
0.31
시가총액:
$6.30M
수익:
-
순이익/손실:
$-22.71M
주가수익비율:
-0.4927
EPS:
-11.71
순현금흐름:
$-18.24M
1주 성능:
-39.96%
1개월 성능:
-31.88%
6개월 성능:
-60.21%
1년 성능:
-94.87%
1일 변동 폭
$5.73
$6.2216
1주일 범위
$5.73
$9.8908
52주 변동 폭
$5.73
$129.50
Genprex Inc Stock (GNPX) Company Profile
명칭
Genprex Inc
전화
512-537-7997
주소
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
GNPX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
5.77 | 6.30M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-01-26 | 개시 | National Securities | Buy |
| 2019-04-29 | 개시 | Noble Capital Markets | Outperform |
Genprex Inc 주식(GNPX)의 최신 뉴스
Genprex Inc. stock retracement – recovery analysisJuly 2025 Summary & Stock Timing and Entry Methods - newser.com
Can Genprex Inc. (2DE0) stock reach $200 price targetJuly 2025 Setups & Low Risk Profit Maximizing Plans - newser.com
How Genprex Inc. stock responds to policy changesStock Surge & AI Based Buy and Sell Signals - newser.com
Tools to monitor Genprex Inc. recovery probability2025 Volatility Report & Safe Capital Preservation Plans - newser.com
Can Genprex Inc. (2DE0) stock sustain margin levelsJuly 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
How to integrate Genprex Inc. into portfolio analysis toolsGold Moves & Expert Approved Trade Ideas - newser.com
What indicators show strength in Genprex Inc.2025 Top Decliners & Technical Pattern Recognition Alerts - newser.com
Backtesting results for Genprex Inc. trading strategiesWeekly Stock Analysis & Short-Term Trading Alerts - newser.com
Can Genprex Inc. (2DE0) stock stage a strong rebound this quarterJuly 2025 Catalysts & Advanced Technical Signal Analysis - newser.com
Why Genprex Inc. stock is popular among millennialsJuly 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com
Will Genprex Inc. stock deliver consistent dividends2025 Big Picture & High Win Rate Trade Alerts - newser.com
Will Genprex Inc. stock reach Wall Street targetsEarnings Overview Summary & AI Enhanced Trade Execution Alerts - newser.com
Is Genprex Inc. stock ready for a breakout2025 Price Targets & Fast Entry High Yield Stock Tips - newser.com
Can technical indicators confirm Genprex Inc.’s reversalQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
How institutional ownership impacts Genprex Inc. stockJuly 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
How Genprex Inc. (2DE0) stock reacts to Fed tightening2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com
Why analysts recommend Genprex Inc. (2DE0) stockJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
What technical models suggest about Genprex Inc.’s comebackJuly 2025 WrapUp & Advanced Swing Trade Entry Plans - newser.com
Why OUTFRONT Media Inc. stock attracts strong analyst attention - newser.com
Why Genprex Inc. stock remains undervaluedTreasury Yields & Community Verified Trade Alerts - newser.com
Genprex, Inc.Common Stock (NQ: GNPX - FinancialContent
Genprex Announces Securities Purchase Agreement and Offering - TipRanks
Genprex sells 377,780 shares; issues warrants up to 755,560 - Stock Titan
Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Eastern Progress
Genprex Inc (GNPX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):